Cat. No.: HY-14452A

Fatostatin hydrobromide

(Synonyms: 125B11 hydrobromide)

56 Cited Publications

고객리뷰

Based on 56 publication(s) in Google Scholar

Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Purity: 99.52%
CAS No.: 298197-04-3
화학식: C₁₈H₁₉BrN₂S
분자량:375.33

보관:

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Fatostatin hydrobromide Chemical Structure

CAS No.: 298197-04-3

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
Chemical Information
Publications (56)
용액&용해도
- In Vitro
- In Vivo
순도&문서
References
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

In Vitro

Fatostatin hydrobromide (125B11 hydrobromide) (0.1-1 μM; 3 days) inhibits the androgen-independent prostate cancer cell proliferation (IC₅₀=0.1 μM) in an independent of the known IGF1-signaling pathway. Fatostatin hydrobromide inhibits insulin-induced adipogenesis of 3T3-L1 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:

DU-145 cells
Concentration:

0.1, 1 μM
Incubation Time:

3 days
Result:

Impaired the IGF1-induced growth at an IC₅₀ of 0.1 μM.

In Vivo

Fatostatin hydrobromide (125B11 hydrobromide) (30 mg/kg; 150 mL; i.p.; daily for 28 days) reduces adiposity, ameliorates fatty liver by reducing triglyceride (TG) storage, and lowers hyperglycemia in ob/ob mice^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Four-to-five-week-old homozygous male obese (ob/ob) mice (C57BL/6J)^[2]
Dosage:

30 mg/kg; 150 mL
Administration:

i.p. injection; daily for 28 days
Result:

Blocked increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake.

Chemical Information

CAS No. 298197-04-3
Appearance Solid
분자량 375.33
화학식 C₁₈H₁₉BrN₂S
Color Light yellow to yellow
SMILES

CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1.[H]Br
Synonyms

125B11 hydrobromide
선적

Room temperature in continental US; may vary elsewhere.
보관

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Publications (56)

All 2D/3D Cell Culture and DifferentiationWBCell Proliferation/Viability Assay

Sort by:

Journal Impact Factor

Nature

A metabolic alarmin from keratinocytes potentiates systemic humoral immunity. [Abstract]

2026 Apr;652(8108):209-219. PMID: 41781621
Cancer Cell

Midkine as a driver of age-related changes and increase in mammary tumorigenesis. [Abstract]

2024 Sep 26:S1535-6108(24)00350-7. PMID: 39366375

Fatostatin hydrobromide purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 Sep 26:S1535-6108(24)00350-7. [Abstract]

Representative images of rat mammary organoids treated with Midkine (300 ng/mL), Betulin (5 μM), Fatostatin (5 μM) and Rapamycin (25 nM) for 5 days.

Fatostatin hydrobromide purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 Sep 26:S1535-6108(24)00350-7. [Abstract]

Immunoblot showing the expression of MDK, mature SREBF1 (SREBF1 (M)), S6, p-S6(Ser235/236), AKT, p-AKT(Ser473) in the organoids treated with Midkine (300 ng/mL), Betulin (5 μM), Fatostatin (5 μM) and Rapamycin (25 nM) for 5 days. Tubulin serves as loading control.
Cell Metab

TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis. [Abstract]

2021 Aug 3;33(8):1655-1670.e8. PMID: 34015269
Cell Mol Immunol

YDJC restrains Th1 cell differentiation by blocking SREBP2-mediated cholesterol biosynthesis to alleviate mucosal inflammation in inflammatory bowel disease. [Abstract]

2025 Oct 29. PMID: 41162693
Autophagy

Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway. [Abstract]

2021 Jul;17(7):1592-1613. PMID: 32432943
Nat Commun

The UFL1-AKT positive feedback loop promotes breast cancer progression by enhancing lipid synthesis. [Abstract]

2026 Jan 20;17(1):614. PMID: 41559041
Nat Commun

Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation. [Abstract]

2025 Feb 25;16(1):1774. PMID: 40000627

Fatostatin hydrobromide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 25;16(1):1774. [Abstract]

Viable cell numbers and PUFA-PC ratio after treatment with LY294002 (iPI3K, 10 µM), Picropodophyllin (iRTK, 10 µM), Ipatasertib (iAkt, 10 µM), or Fatostatin (iSREBP1, 20 µM) for 48 h.
Nat Commun

Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism. [Abstract]

2025 Feb 1;16(1):1241. PMID: 39890808
J Clin Invest

ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis. [Abstract]

2025 Jul 8:e193134. PMID: 40627441
J Exp Clin Cancer Res

The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. [Abstract]

2019 May 29;38(1):228. PMID: 31142342
Adv Sci (Weinh)

Malignant Hepatoblast-Like Cells Sustain Stemness via IGF2-Dependent Cholesterol Accumulation in Hepatoblastoma. [Abstract]

2025 Apr 24:e2407671. PMID: 40271711
Cell Death Differ

Site-1 protease controls osteoclastogenesis by mediating LC3 transcription. [Abstract]

2021 Jun;28(6):2001-2018. PMID: 33469231
Cell Death Dis

GIPC2 regulation of the PKM2/SREBP1 signaling axis controls adipogenic differentiation of mesenchymal stem cells. [Abstract]

2026 Jan 7;17(1):5. PMID: 41500998
Cell Death Dis

MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis. [Abstract]

2025 May 16;16(1):391. PMID: 40379644
Cell Mol Biol Lett

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation. [Abstract]

2024 Aug 21;29(1):112. PMID: 39169280
Cell Death Dis

MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing. [Abstract]

2024 Jun 12;15(6):411. PMID: 38866777
Cell Death Dis

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. [Abstract]

2021 May 26;12(6):544. PMID: 34039951
Cancer Lett

PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer. [Abstract]

2024 Jun 18:217068. PMID: 38901665
Cell Death Discov

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. [Abstract]

2022 Oct 28;8(1):431. PMID: 36307402

Fatostatin hydrobromide purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Oct 28;8(1):431. [Abstract]

NUPR1 overexpression‐induced lipogenic enzymes expression can be suppressed by co-incubation with Fatostatin (20 μM; 48 h) in MHCC-97H and SK-Hep1 cells.

Fatostatin hydrobromide purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Oct 28;8(1):431. [Abstract]

Transwell migration assay. Fatostatin reduces the migration ability of NUPR1-overexpressing MHCC-97H cells.
NPJ Precis Oncol

SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. [Abstract]

2024 Mar 1;8(1):58. PMID: 38429411
Mol Med

G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis. [Abstract]

2024 Feb 21;30(1):28. PMID: 38383297
Free Radic Biol Med

FATP5 deficiency alleviates MASH via remodeling hepatic lipid composition to suppress ferroptosis. [Abstract]

2025 Aug 19:240:170-182. PMID: 40840619
Cancer Immunol Res

Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFN-γ-ΙRF1-SREBF2 Axis. [Abstract]

2025 Dec 9. PMID: 41364085
Cell Rep

HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylation. [Abstract]

2025 Feb 19;44(3):115339. PMID: 39977267
Cell Rep

Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. [Abstract]

2022 Nov 29;41(9):111738. PMID: 36450259
Emerg Microbes Infect

SREBP2-dependent lipid droplet formation enhances viral replication and deteriorates lung injury in mice following IAV infection. [Abstract]

2025 Dec;14(1):2470371. PMID: 39968754
J Ethnopharmacol

Paris polyphylla Smith var. yunnanensis-derived saponins potentiate the antitumor activity of GPX4 inhibitors. [Abstract]

2026 Feb 28:357:120890. PMID: 41232632
JCI Insight

Regulatory T-cell and neutrophil extracellular traps interaction contributes to the development of immunosuppression in sepsis. [Abstract]

2024 Jun 18:e180132. PMID: 38888975
J Ethnopharmacol

Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis. [Abstract]

2024 Jan 30;319(Pt 1):117162. PMID: 37690477
Cell Mol Life Sci

Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation. [Abstract]

2025 Jul 3;82(1):270. PMID: 40610622
Cell Mol Life Sci

Human cytomegalovirus infection impairs neural differentiation via repressing sterol regulatory element binding protein 2-mediated cholesterol biosynthesis. [Abstract]

2024 Jul 6;81(1):289. PMID: 38970696
Cell Biosci

Gut microbial metabolite deoxycholic acid facilitates Th17 differentiation through modulating cholesterol biosynthesis and participates in high-fat diet-associated colonic inflammation. [Abstract]

2023 Oct 3;13(1):186. PMID: 37789469
Commun Biol

Pyruvate carboxylase promotes SREBP1a-mediated lipid synthesis in epithelial ovarian cancer. [Abstract]

2026 May 14. PMID: 42129486
Eur J Pharmacol

Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression. [Abstract]

2025 Sep 15:1003:177890. PMID: 40617382
Int Immunopharmacol

Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation. [Abstract]

2024 Jul 18:139:112669. PMID: 39029231
Am J Respir Cell Mol Biol

Pathogenic Rewiring of IL6 Signaling Fuels Macrophage Immunometabolic reprogramming in COPD. [Abstract]

2026 Jun 23:aanag113. PMID: 42334931
J Pathol

ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. [Abstract]

2020 Dec;252(4):358-370. PMID: 32770671
Cancers (Basel)

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters. [Abstract]

2023 Jun 3;15(11):3043. PMID: 37297005
J Cell Mol Med

Identification of FADS2 as a Contributor of Ferroptosis Escape in Bladder Cancer. [Abstract]

2025 Jul;29(14):e70710. PMID: 40682485
Oncol Rep

Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. [Abstract]

2018 Apr;39(4):1919-1929. PMID: 29436682
Mol Oncol

Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis. [Abstract]

2025 Jun;19(6):1668-1686. PMID: 39425259
iScience

Influenza A virus infection activates STAT3 to enhance SREBP2 expression, cholesterol biosynthesis, and virus replication. [Abstract]

2024 Jun 29;27(8):110424. PMID: 39108727
J Virol

Pvf/Pvr signaling relieves white spot syndrome virus-induced lipid consumption to inhibit viral infection in shrimp. [Abstract]

2026 Apr 29:e0018226. PMID: 42053404
Biochim Biophys Acta Mol Cell Biol Lipids

Tumor necrosis factor alpha-induced activation of SREBP2 promotes cholesterol biosynthesis in cholestasis. [Abstract]

2025 Jun 6:159642. PMID: 40484275
Mol Carcinog

LATS-regulated nuclear-cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial-mesenchymal transition. [Abstract]

2023 Jul;62(7):963-974. PMID: 37042569
Exp Eye Res

SREBP1-driven SCD1 protects retinal pigment epithelium from oxidative damage by activating the NRF2/GPX4 axis. [Abstract]

2026 May:266:110932. PMID: 41720386
Tissue Cell

Intracellullar cholesterol accumulation caused by HBV induces ATF6-mediated endoplasmic reticulum stress to trigger endoplasmic reticulophagy. [Abstract]

2025 Sep 9:98:103134. PMID: 40934546
Exp Eye Res

SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells. [Abstract]

2025 Jan 10:110239. PMID: 39800283
Br J Nutr

Dietary palm oil enhances SREBP2-mediated cholesterol biosynthesis through inducing endoplasmic reticulum stress in muscle of large yellow croaker ( Larimichthys crocea). [Abstract]

2024 Feb 28;131(4):553-566. PMID: 37699661
Anal Cell Pathol

Identification of the Antioxidant Enzyme B166 as a Novel Biomarker for Patients With Glioblastoma Multiforme. [Abstract]

2026;2026(1):e6120748. PMID: 41810932
Oncol Lett

SREBP1 silencing inhibits the proliferation and motility of human esophageal squamous carcinoma cells via the Wnt/β-catenin signaling pathway. [Abstract]

2020 Sep;20(3):2855-2869. PMID: 32765792
Biol Pharm Bull

Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer. [Abstract]

2022 Apr 1;45(4):438-445. PMID: 35110426
Res Sq

2026 Jun 15.
University of Tubingen

2025.
Res Sq

2024 Nov 18.
Research Square Preprint

2022 May.

용액&용해도

In Vitro:

DMSO : 25 mg/mL (66.61 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.6643 mL

13.3216 mL

26.6432 mL

5 mM

0.5329 mL

2.6643 mL

5.3286 mL

10 mM

0.2664 mL

1.3322 mL

2.6643 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.08 mg/mL (5.54 mM); Clear solution

This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: 1 mg/mL (2.66 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 1 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (274 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Choi Y, et al. Identification of bioactive molecules by adipogenesis profiling of organic compounds. J Biol Chem. 2003 Feb 28;278(9):7320-4. [Content Brief]

[2]. Kamisuki S, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009 Aug 28;16(8):882-92. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.6643 mL	13.3216 mL	26.6432 mL	66.6081 mL
	5 mM	0.5329 mL	2.6643 mL	5.3286 mL	13.3216 mL
	10 mM	0.2664 mL	1.3322 mL	2.6643 mL	6.6608 mL
	15 mM	0.1776 mL	0.8881 mL	1.7762 mL	4.4405 mL
	20 mM	0.1332 mL	0.6661 mL	1.3322 mL	3.3304 mL
	25 mM	0.1066 mL	0.5329 mL	1.0657 mL	2.6643 mL
	30 mM	0.0888 mL	0.4441 mL	0.8881 mL	2.2203 mL
	40 mM	0.0666 mL	0.3330 mL	0.6661 mL	1.6652 mL
	50 mM	0.0533 mL	0.2664 mL	0.5329 mL	1.3322 mL
	60 mM	0.0444 mL	0.2220 mL	0.4441 mL	1.1101 mL

Keywords

Fatostatin hydrobromide

56 Cited Publications

100 mg 견적 받기

Subscribe to the

MedChemExpress

Newsletter

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

Fatostatin hydrobromide

Immunology/Inflammation Compound Library

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Lipid Metabolism Compound Library

Heterocyclic Compound Library

Metabolic Enzyme Compound Library

Highly Selective Inhibitors Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) Fatostatin hydrobromide

Biological Activity

Chemical Information

Publications (56)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

Fatostatin hydrobromide

Immunology/Inflammation Compound Library

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Lipid Metabolism Compound Library

Heterocyclic Compound Library

Metabolic Enzyme Compound Library

Highly Selective Inhibitors Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) Fatostatin hydrobromide

Biological Activity

Chemical Information

Publications (56)

용액&용해도

순도&문서

References

Help & FAQs

Complete Stock Solution Preparation Table

Fatostatin hydrobromide Related Classifications

HY-14452A Related Classifications